Chemoinformaics analysis of Mono-O-acetylacoschimperoside P
| Molecular Weight | 634.763 | nRot | 6 |
| Heavy Atom Molecular Weight | 584.363 | nRig | 33 |
| Exact Molecular Weight | 634.335 | nRing | 6 |
| Solubility: LogS | -4.354 | nHRing | 2 |
| Solubility: LogP | 3.042 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 95 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 0 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 98.9417 |
| nHD | 2 | BPOL | 63.1804 |
| QED | 0.305 |
| Synth | 5.459 |
| Natural Product Likeliness | 2.543 |
| NR-PPAR-gamma | 0.4 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.976 |
| Pgp-sub | 0.338 |
| HIA | 0.945 |
| CACO-2 | -5.169 |
| MDCK | 0.0000551 |
| BBB | 0.428 |
| PPB | 0.919302 |
| VDSS | 1.301 |
| FU | 0.093508 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.104 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.409 |
| CYP2c9-inh | 0.047 |
| CYP2c9-sub | 0.068 |
| CYP2d6-inh | 0.04 |
| CYP2d6-sub | 0.18 |
| CYP3a4-inh | 0.143 |
| CYP3a4-sub | 0.469 |
| CL | 4.41 |
| T12 | 0.062 |
| hERG | 0.065 |
| Ames | 0.033 |
| ROA | 0.993 |
| SkinSen | 0.015 |
| Carcinogencity | 0.05 |
| EI | 0.005 |
| Respiratory | 0.289 |
| NR-Aromatase | 0.807 |
| Antiviral | Yes |
| Prediction | 0.769776 |